INNOVIVA INC (INVA) Stock News

NASDAQ:INVA - Nasdaq - US45781M1018 - Common Stock - Currency: USD

20.43 +0.34 (+1.69%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

INVA Latest News, Press Relases and Analysis

All

Press Releases

5 hours ago - By: Innoviva Specialty Therapeutics, Inc.

Innoviva Specialty Therapeutics’ Antimicrobial Therapies ZEVTERA® and XACDURO® Nominated for the 2025 Prix Galien USA Best Pharmaceutical Product Award

2 days ago - By: Benzinga

Expert Outlook: Innoviva Through The Eyes Of 4 Analysts

2 days ago - By: Yahoo Finance - Mentions: MS CMI HSBC LINE ...

Arm initiated, Adobe downgraded: Wall Street's top analyst calls

2 days ago - By: Benzinga - Mentions: ALM ARM CBIO

This Arm Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday

7 days ago - By: The Motley Fool

Innoviva (INVA) Q2 Sales Jump 64%

7 days ago - By: Innoviva, Inc.

Innoviva Reports Second Quarter 2025 Financial Results; Highlights Recent Company Progress

2 months ago - By: Innoviva Specialty Therapeutics, Inc.

FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025

2 months ago - By: Innoviva, Inc.

Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults

2 months ago - By: Innoviva, Inc.

Innoviva to Participate in Upcoming Investor Conferences

3 months ago - By: Innoviva Specialty Therapeutics, Inc.

ZEVTERA® (ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic Now Commercially Available in the U.S. to Treat Three Types of Bacterial Infections

3 months ago - By: Yahoo Finance - Mentions: MSFT AMZN

Innoviva, Inc. (INVA): Among Stocks with Insanely High PE Ratios Insiders Are Selling

a year ago - By: BusinessInsider

News Image

INVA Stock Earnings: Innoviva Misses EPS, Beats Revenue for Q2 2024

3 months ago - By: Innoviva, Inc.

Innoviva Reports First Quarter 2025 Financial Results; Highlights Recent Company Progress

5 months ago - By: Armata Pharmaceuticals, Inc.

Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement with Innoviva

5 months ago - By: Innoviva, Inc.

Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference

6 months ago - By: Innoviva, Inc.

Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress

6 months ago - By: Innoviva, Inc.

Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

8 months ago - By: Innoviva, Inc.

Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (ceftobiprole)

9 months ago - By: Innoviva, Inc.

Innoviva to Participate in the Citi 2024 Global Healthcare Conference

9 months ago - By: Innoviva, Inc.

Innoviva to Participate in the UBS Global Healthcare Conference

9 months ago - By: Innoviva, Inc.

Innoviva Reports Third Quarter 2024 Financial Results; Highlights Recent Company Progress

a year ago - By: Innoviva, Inc.

Innoviva to Participate in Upcoming Investor Conferences

a year ago - By: InvestorPlace

INVA Stock Earnings: Innoviva Misses EPS, Beats Revenue for Q2 2024

a year ago - By: Innoviva, Inc.

Innoviva Reports Second Quarter 2024 Financial Results; Highlights Recent Company Progress

a year ago - By: InvestorPlace - Mentions: SEM CARS GSK

The 3 Most Undervalued Under-$50 Stocks to Buy in July 2024

a year ago - By: InvestorPlace - Mentions: SILV GSL ARMP

3 Once-in-a-Lifetime Stock Picks Due for an Unprecedented Surge